New patent expiration for Endo Pharms drug MEGACE ES
Annual Drug Patent Expirations for MEGACE+ES Megace Es is a drug marketed by Endo Pharms Inc and is included in one NDA. There are five patents protecting this drug and…
Source
Annual Drug Patent Expirations for MEGACE+ES Megace Es is a drug marketed by Endo Pharms Inc and is included in one NDA. There are five patents protecting this drug and…
Source
Annual Drug Patent Expirations for SOOLANTRA Soolantra is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from three suppliers. There are twelve…
Source
Get new actionable insights and updates from BiotechBlog